合計 50 件の最近のインサイダー取引記録が記録されています Cassava Sciences, Inc. (SAVA), 内訳は 38 件の買い および 6 件の売り. インサイダー買い総額は $51.4M インサイダー売り総額は $5.53M.
最近活動のある主要インサイダーには Gussin Robert Z, O Donnell Michael J, Nicaise Claude. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — SAVA
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-05-23 |
Gussin Robert Z |
Director |
RSU 付与（制限付株式） |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-05-23 |
O Donnell Michael J |
Director |
RSU 付与（制限付株式） |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-05-23 |
Nicaise Claude |
Director |
RSU 付与（制限付株式） |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-05-23 |
Gravier Pierre |
Director |
RSU 付与（制限付株式） |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-05-23 |
Anderson Robert Eugene Jr |
Director |
RSU 付与（制限付株式） |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-04-17 |
Schoen Eric |
Chief Financial Officer |
RSU 付与（制限付株式） |
100,000 |
$1.44 |
$144K |
100,000 |
| 2025-04-17 |
Barry Richard |
President & CEO |
RSU 付与（制限付株式） |
350,000 |
$1.44 |
$504K |
350,000 |
| 2025-04-17 |
Cook Robert Christopher |
Chief Operating & Legal Office |
RSU 付与（制限付株式） |
100,000 |
$1.44 |
$144K |
100,000 |
| 2025-04-17 |
Nassif Freda |
Chief Business Officer |
RSU 付与（制限付株式） |
100,000 |
$1.44 |
$144K |
100,000 |
| 2024-11-29 |
Schoen Eric |
Chief Financial Officer |
オプション行使（売却） |
50,000 |
$1.18 |
$59K |
- |
| 2024-11-29 |
Kupiec James William |
Chief Medical Officer |
情報に基づく売り |
4,000 |
$3.87 |
$15.48K |
- |
| 2024-11-18 |
Nassif Freda |
Officer |
不明 |
- |
- |
- |
- |
| 2024-11-18 |
Nassif Freda |
Chief Commercial Officer |
RSU 付与（制限付株式） |
100,000 |
$27.95 |
$2.8M |
100,000 |
| 2024-11-18 |
Landen Jaren |
Chief Clinical Dev. Officer |
不明 |
15,000 |
$26.57 |
$398.55K |
- |
| 2024-11-18 |
Landen Jaren |
Chief Clinical Dev. Officer |
RSU 付与（制限付株式） |
85,000 |
$27.95 |
$2.38M |
85,000 |
| 2024-10-01 |
Barry Richard |
President & CEO |
RSU 付与（制限付株式） |
600,000 |
$27.42 |
$16.45M |
600,000 |
| 2024-09-06 |
Schoen Eric |
Chief Financial Officer |
RSU 付与（制限付株式） |
100,000 |
$26.91 |
$2.69M |
100,000 |
| 2024-09-06 |
Kupiec James William |
Chief Medical Officer |
RSU 付与（制限付株式） |
100,000 |
$26.91 |
$2.69M |
100,000 |
| 2024-09-06 |
Cook Robert Christopher |
SVP & General Counsel |
RSU 付与（制限付株式） |
100,000 |
$26.91 |
$2.69M |
100,000 |
| 2024-05-20 |
Barbier Remi |
President & CEO |
RSU 付与（制限付株式） |
50,000 |
$22.10 |
$1.11M |
50,000 |
| 2024-05-20 |
Schoen Eric |
Chief Financial Officer |
RSU 付与（制限付株式） |
25,000 |
$22.10 |
$552.5K |
25,000 |
| 2024-05-20 |
Kupiec James William |
Chief Medical Officer |
RSU 付与（制限付株式） |
10,000 |
$22.10 |
$221K |
10,000 |
| 2024-05-20 |
Cook Robert Christopher |
SVP & General Counsel |
RSU 付与（制限付株式） |
10,000 |
$22.10 |
$221K |
10,000 |
| 2024-05-16 |
Robertson Sanford |
Director |
贈与（受領） |
5,000 |
- |
- |
5,000 |
| 2024-05-09 |
Scannon Patrick J Md Phd |
Director |
RSU 付与（制限付株式） |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-05-09 |
Gussin Robert Z |
Director |
RSU 付与（制限付株式） |
15,000 |
$21.11 |
$316.65K |
15,000 |
| 2024-05-09 |
O Donnell Michael J |
Director |
RSU 付与（制限付株式） |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-05-09 |
Robertson Sanford |
Director |
RSU 付与（制限付株式） |
15,000 |
$21.11 |
$316.65K |
15,000 |
| 2024-05-09 |
Barry Richard |
Director |
RSU 付与（制限付株式） |
15,000 |
$21.11 |
$316.65K |
15,000 |
| 2024-05-09 |
Nicaise Claude |
Director |
RSU 付与（制限付株式） |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-05-09 |
Gravier Pierre |
Director |
RSU 付与（制限付株式） |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-05-09 |
Anderson Robert Eugene Jr |
Director |
RSU 付与（制限付株式） |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-04-26 |
Robertson Sanford |
Director |
オプション行使（売却） |
46,000 |
$33.00 |
$1.52M |
308,740 |
| 2024-04-23 |
Barry Richard |
Director |
オプション行使（売却） |
117,390 |
$33.00 |
$3.87M |
- |
| 2024-04-18 |
Kupiec James William |
Chief Medical Officer |
オプション行使（売却） |
1,000 |
$33.00 |
$33K |
- |
| 2024-04-17 |
Schoen Eric |
Chief Financial Officer |
オプション行使（売却） |
1,000 |
$33.00 |
$33K |
6,920 |
| 2024-01-03 |
Schoen Eric |
Chief Financial Officer |
RSU 付与（制限付株式） |
800 |
$33.00 |
$26.4K |
800 |
| 2024-01-03 |
Kupiec James William |
Chief Medical Officer |
RSU 付与（制限付株式） |
1,000 |
$33.00 |
$33K |
1,000 |
| 2024-01-03 |
Barry Richard |
Director |
RSU 付与（制限付株式） |
117,390 |
$33.00 |
$3.87M |
176,085 |
| 2024-01-03 |
Robertson Sanford |
Director |
RSU 付与（制限付株式） |
72,000 |
$33.00 |
$2.38M |
72,000 |
| 2023-12-06 |
Gravier Pierre |
Director |
不明 |
- |
- |
- |
- |
| 2023-12-06 |
Gravier Pierre |
Director |
RSU 付与（制限付株式） |
20,000 |
$21.71 |
$434.2K |
20,000 |
| 2023-12-06 |
Anderson Robert Eugene Jr |
Director |
不明 |
- |
- |
- |
- |
| 2023-12-06 |
Anderson Robert Eugene Jr |
Director |
RSU 付与（制限付株式） |
20,000 |
$21.71 |
$434.2K |
20,000 |
| 2023-12-06 |
Nicaise Claude |
Director |
不明 |
- |
- |
- |
- |
| 2023-12-06 |
Nicaise Claude |
Director |
RSU 付与（制限付株式） |
20,000 |
$21.71 |
$434.2K |
20,000 |
| 2023-10-03 |
Barbier Remi |
President & CEO |
RSU 付与（制限付株式） |
150,000 |
$17.54 |
$2.63M |
150,000 |
| 2023-10-03 |
Schoen Eric |
Chief Financial Officer |
RSU 付与（制限付株式） |
150,000 |
$17.54 |
$2.63M |
150,000 |
| 2023-10-03 |
Kupiec James William |
Chief Medical Officer |
RSU 付与（制限付株式） |
150,000 |
$17.54 |
$2.63M |
150,000 |
| 2023-10-03 |
Cook Robert Christopher |
SVP & General Counsel |
RSU 付与（制限付株式） |
50,000 |
$17.54 |
$877K |
50,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
